Study | Screened | Entered | Completed | % Screened | % Entered | Mean hours used (control group) |
Bakker 2010 | 751 | 80 | 76 | 10.1 | 95 | 5.2 |
Ballard 2007 | 204 | 104 | 104 | 51 | 100 | 2.9 |
Berry 2014 | 240 | 156 | 131 | 54.5 | 84 | 4 |
Blau 2012 | Not reported | 35 | 32 | N/A | 91 | 5.6 |
Bloch 2018 | 952 | 208 | 172 | 18 | 82 | 5.5 |
Bogan 2017 | Not reported | 70 | 65 | N/A | N/A | 4.81 |
Castronovo 2006 | Not reported | 50 | 40 | N/A | 80 | Not reported |
Chang 2015 | Not reported | 25 | 19 | N/A | 76 | 5.8 |
d'Ortho 2000 | Not reported | 25 | 25 | N/A | 100 | 4.7 |
Damjanovic 2009 | Not reported | 100 | 78 | N/A | 78 | 5.1 |
Dolan 2008 | 222 | 184 | 142 | 64 | 76 | 5.3 |
Ficker 2003 | Not reported | 100 | 95 | N/A | 95 | 4.8 |
Fietze 2007 | Not reported | 21 | 21 | N/A | 100 | 4.2 |
Galetke 2008 | Not reported | 20 | 20 | NA | 100 | 6.4 |
Gay 2003 | Not reported | 40 | 27 | N/A | 67.5 | 5.6 |
Gfüllner 2007 | Not reported | Not reported | 18 | N/A | N/A | 5.3 |
Gonzalez‐Moro 2005 | Not reported | 20 | Not reported | N/A | N/A | Not reported |
Gulati 2015 | 75 | 31 | 28 | 37.3 | 90.3 | 2.2 |
Heiser 2010 | Not reported | 75 | 49 | N/A | 65.3 | 4.3 |
Hudgel 2000 | Not reported | 53 | 39 | N/A | 73.6 | 5.5 |
Hukins 2004 | 58 | 55 | 46 | 79 | 84 | 4.86 |
Hussain 2004 | Not reported | 10 (assumed) | 10 | N/A | 100 | 3.7 |
Jarvis 2006 | Not reported | Not reported | 20 | N/A | N/A | 6.8 |
Kendrick 2002 | Not reported | 41 | 27 | N/A | 65.85 | Not reported |
Konermann 1998 | Not reported | 50 | 48 | N/A | 96 | 5.6 |
Kushida 2011 | 178 | 168 | 140 | 78.7 | 83.3 | 4.6 |
Leidag 2008 | Not reported | 30 | 18 | N/A | 60 | 5.8 |
Loube 2004 | Not reported | Not reported | Not reported | N/A | N/A | Not reported |
Marrone 2004 | Not reported | 22 (assumed) | 22 | N/A | 100 | 4.4 |
Marshall 2008 | Not reported | Not reported | 19 | N/A | NA | 3 |
Masa 2015 | 351 | 221 (numbers reported here reflect participants screened for three treatment arms) | 200 | 57% | 90% | 5.3 |
Massie 2003 | Not reported | 46 | 44 | N/A | 95.6 | 4.5 |
Meurice 1996 | Not reported | 16 | 16 | N/A | 100 | 5.7 |
Meurice 2007 | Not reported | 83 | 65 | N/A | 78 | 6.5 |
Meurice 2009 | Not reported | 20 | 20 | N/A | 100 | 5.3 |
Modrak 2007 | Not reported | Not reported | 26 | N/A | N/A | 5.1 |
Muir 1998 | Not reported | Not reported | 16 | N/A | N/A | 4.9 |
Neill 2003 | Not reported | 42 | 37 | N/A | 88 | 5.3 |
Nilius 2006 | Not reported | 52 | 51 | N/A | 98 | 5.2 |
Nolan 2007 | Not reported | 34 | 29 | N/A | 85 | 4.9 |
Noseda 2004 | 93 | 27 | 24 | 26 | 89 | 5.3 (average usage on 'effective nights') |
Nussbaumer 2006 | Not reported | 34 | 30 | N/A | 88 | 4.8 |
Patruno 2007 | Not reported | 40 | 31 | N/A | 78 | 6.1 |
Pépin 2009 | Not reported | 20 | 20 | N/A | 100 | 5.3 |
Pépin 2016 | 569 | 322 | 281 | 49.4 | 87.3 | 5.2 |
Powell 2012 | 51 | 48 | 47 | 92.2 | 97.9 | 4.4 |
Randerath 2001 | Not reported | 52 | 47 | N/A | 90 | 5.3 |
Reeves‐Hoché 1995 | Not reported | 83 | 62 | N/A | 75 | 5 |
Resta 2004 | Not reported | 20 | 20 | N/A | 100 | 5.3 |
Rochford 2006 | Not reported | N/A | 13 | N/A | N/A | 4.6 |
Rohling 2011 | Not reported | 39 | 33 | N/A | 84.6 | 6.6 |
Rostig 2003 | Not reported | 30 | 30 (assumed) | N/A | 100 (assumed) | 3.8 |
Ruhle 2011 | Not reported | 44 | 44 | N/A | 100 | 4.5 |
Ryan 2009 | 125 | 125 | 112 | 91 | 91 | 5.21 |
Senn 2003 | Not reported | 31 | 29 | N/A | 93.55 | 7.1 |
Sériès 1997 | 39 | 36 | 36 | 92.3 | 100 | Not reported |
Sériès 2001 | Not reported | 48 | 48 (assumed) | N/A | 100 (assumed) | 4.2 |
Soudorn 2016 | 104 | 20 | 20 | 19.2 | 19.2 | 5.2 |
Teschler 2000 | Not reported | 10 | 10 | N/A | 100 | 6.1 |
To 2008 | Not reported | 43 | 41 | N/A | 95 | 3.8 |
Vennelle 2010 | 368 | 200 | 181 | 49.1 | 90.5 | 4 |
Wenzel 2007 | Not reported | 20 (assumed) | 20 | NA | 100 (assumed) | 5.8 |
West 2006 | 633 | 98 | 86 | 16 | 88 | 5.6 |
Worsnop 2010 | Not reported | 54 | 54 (assumed) | N/A | 100 (assumed) | 4.5 |
Abbreviations: N/A: not applicable |